AWM Investment Company’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-650,000
Closed -$1.14M 101
2025
Q1
$1.14M Buy
+650,000
New +$1.48M 0.16% 75
2024
Q3
Sell
-1,350,000
Closed -$3.94M 101
2024
Q2
$3.94M Hold
1,350,000
0.53% 54
2024
Q1
$4.91M Hold
1,350,000
0.64% 48
2023
Q4
$2.04M Sell
1,350,000
-75,000
-5% -$96.5K 0.27% 73
2023
Q3
$1.91M Hold
1,425,000
0.28% 69
2023
Q2
$2.56M Sell
1,425,000
-100,000
-7% -$170K 0.35% 60
2023
Q1
$2.53M Buy
1,525,000
+900,000
+144% +$1.82M 0.34% 62
2022
Q4
$1.2M Buy
625,000
+270,000
+76% +$546K 0.17% 80
2022
Q3
$795K Buy
355,000
+15,000
+4% +$42.8K 0.12% 98
2022
Q2
$1.1M Sell
340,000
-60,000
-15% -$262K 0.17% 93
2022
Q1
$2.1M Sell
400,000
-300,000
-43% -$1.69M 0.27% 81
2021
Q4
$5.95M Buy
700,000
+300,000
+75% +$2.76M 0.6% 55
2021
Q3
$3.98M Sell
400,000
-46,024
-10% -$417K 0.39% 64
2021
Q2
$4.15M Buy
446,024
+10,200
+2% +$116K 0.41% 70
2021
Q1
$4.55M Buy
+435,824
New +$4.87M 0.51% 60

Other funds holding NUVB

AWM Investment Company's NUVB Position: Q2 2025 in Review

AWM Investment Company sold out of Nuvation Bio (NUVB) in Q2 2025, closing a stake of 650,000 shares — an estimated $1.14M sold.

AWM Investment Company first reported a position in NUVB in Q1 2021 and held it in 15 quarters. The position peaked at $5.95M in Q4 2021. 182 funds tracked by Wall St. Rank hold NUVB as of Q2 2025.

  • AWM Investment Company reported no remaining Nuvation Bio position as of Q2 2025 after selling out during the quarter.
  • AWM Investment Company sold 650,000 Nuvation Bio shares in Q2 2025, an estimated $1.14M.
  • AWM Investment Company first reported a position in Nuvation Bio in Q1 2021 and held it in 15 quarters.
  • AWM Investment Company's Nuvation Bio position peaked at $5.95M in Q4 2021.
  • 182 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2025.

Based on AWM Investment Company's 13F filing for Q2 2025, filed 14 Aug 2025.